Search

Zai Lab Ltd ADR

Chiusa

SettoreSettore sanitario

26.72 1.67

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

25.66

Massimo

26.63

Metriche Chiave

By Trading Economics

Entrata

191K

-51M

Vendite

6.7M

106M

EPS

-0.46

Margine di Profitto

-47.808

Dipendenti

1,784

EBITDA

-2.1M

-46M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+53.05% upside

Dividendi

By Acuity

Utili prossimi

5 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

737M

2.8B

Apertura precedente

25.05

Chiusura precedente

26.72

Notizie sul Sentiment di mercato

By Acuity

38%

62%

76 / 339 Classifica in Healthcare

Zai Lab Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

21 set 2026, 23:52 UTC

News

Boeing Co. has secured two defense contracts worth $41.5 million, while shares have declined slightly in after-market trading, remaining near the lower end of their one-month range.

21 set 2026, 23:51 UTC

News

BlackRock Inc. is trading modestly lower in after-market hours, following the launch of its customizable LifePath Solutions target date framework.

21 set 2026, 23:50 UTC

News

Northrop Grumman Corp is trading modestly lower in after-market hours, retracing from a peak and positioned below its 20-day moving average.

21 set 2026, 23:36 UTC

Correlated Moves
News

The USD/DKK is trading higher as the People's Bank of China maintained its one-year Loan Prime Rate at 3.00%, signaling stable monetary policy.

21 set 2026, 23:31 UTC

News

Tapestry Inc is trading modestly higher in after-market hours, with a current market capitalization of $22.56 billion, following three consecutive lower closes.

21 set 2026, 23:25 UTC

News

Pentair PLC declared a $0.27 quarterly dividend amid a class action lawsuit alleging securities fraud, with shares modestly lower in after-market trading.

21 set 2026, 23:15 UTC

News

TransDigm Group Inc. announced its Extant Aerospace unit will acquire assets for approximately $240 million, driving the stock higher in after-market hours.

21 set 2026, 23:15 UTC

News

Baidu Inc faces two class action lawsuits alleging securities fraud, contributing to a slight decline in after-market trading amid ongoing financial concerns.

21 set 2026, 23:11 UTC

Social Media
News

Eli Lilly has started construction on a $6.5 billion facility in Houston to produce its GLP-1 receptor agonist, Foundayo, creating over 600 permanent jobs.

21 set 2026, 23:11 UTC

Social Media
News

Intel Corp shares advanced during after-market hours, supported by a record-high Nasdaq close and favorable conditions from falling Treasury yields and oil prices.

21 set 2026, 23:06 UTC

News

Weyerhaeuser Co announced a $1 million investment in Drayton Valley, Alberta, marking its first Thrive program initiative in Canada, with shares modestly higher in after-market trading.

21 set 2026, 23:06 UTC

News
Correlated Moves

Coinbase Global Inc is launching an IPO allocation service for U.S. customers and ceasing sports wagering in Michigan, with shares trading higher in after-market hours.

21 set 2026, 23:06 UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by a broader cryptocurrency rally and increased interest from large holders amid positive regulatory developments.

21 set 2026, 23:06 UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by regulatory developments and increased interest from large holders amid a broader cryptocurrency rally.

21 set 2026, 23:05 UTC

News

Biogen Inc. is trading slightly higher in after-market hours following approvals for at-home LEQEMBI in Japan and China and new Phase 3 data for EMPAVELI.

21 set 2026, 23:02 UTC

News
Social Media

GameStop shares rose in after-hours trading as CEO Ryan Cohen disclosed the purchase of 1.15M shares for about $26.4 million, increasing his ownership to 40.5 million.

21 set 2026, 23:02 UTC

News

Bitcoin is sharply higher today, reaching its highest level since January, amid a broader cryptocurrency rally and positive U.S.-China trade developments.

21 set 2026, 23:02 UTC

News

Bitcoin surged today to its highest level since January, driven by positive U.S.-China trade developments and easing inflation concerns, despite an earlier pullback.

21 set 2026, 23:01 UTC

News

Decline in after-market trading after CMS announces potential fee cuts.

21 set 2026, 23:01 UTC

News

Thor Industries shares rose in after-market trading following Keystone RV's record sales at the Hershey RV Show, attributed to strong dealer preparation and customer interest.

21 set 2026, 23:01 UTC

News

Salesforce Inc shares are advancing in after-market trading following director David Kirk's acquisition of 4.18k shares for approximately $999.5k.

21 set 2026, 23:01 UTC

News
Social Media

Vicor Corporation raised its Q3 2026 growth guidance from nearly 10% to over 20%, driving a sharp rise in its share price during after-hours trading.

21 set 2026, 23:01 UTC

News

General Motors Co's stock is higher in after-market trading following a $697.7 million contract modification awarded to GM Defense LLC by the U.S. Department of War.

21 set 2026, 23:01 UTC

News

DICK'S Sporting Goods Inc faces class action lawsuits over alleged securities fraud, contributing to a modest decline in after-market trading following disappointing earnings.

21 set 2026, 23:01 UTC

Macro News
Correlated Moves
News

The U.S. dollar is consolidating against the yen, currently around JPY156.50, with options worth $2.3 billion expiring today.

21 set 2026, 23:00 UTC

News

Endava PLC's shares have declined sharply in after-market trading following the appointment of Conor McShane as Interim CFO amid an accounting investigation.

21 set 2026, 22:51 UTC

News
Social Media

Robinhood Markets Inc's stock is trading lower after-hours, reversing from a high of $126.41 earlier in the session amid a recovering cryptocurrency market.

21 set 2026, 22:01 UTC

News

In after-market trading, Gartner Inc. has moved higher following five consecutive lower daily closes, despite remaining below its 20-day moving average.

21 set 2026, 21:01 UTC

News
Event

AnaptysBio reported Q2 net income of $183.88 million and EPS of $5.11, exceeding expectations, leading to a rise in after-market trading.

21 set 2026, 20:12 UTC

News
Correlated Moves

NBT Bancorp Inc. is trading higher in after-market hours following the announcement of Kimberly A. Boynton's appointment to its Board of Directors, effective October 1, 2026.

Confronto tra pari

Modifica del prezzo

Zai Lab Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

53.05% in crescita

Previsioni per 12 mesi

Media 39.333 USD  53.05%

Alto 45 USD

Basso 36 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zai Lab Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

3

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

76 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.